Key result
Interdisciplinary pharmacy care improves heart failure quality of life by ~8 points over usual care.
Why the study?
Patients with heart failure have impaired quality of life, and it is unknown how an interdisciplinary intervention involving frequent structured community pharmacy visits affects quality of life.
Does an interdisciplinary pharmacist/physician intervention involving regular structured pharmacy visits and weekly dosing aids improve health-related quality of life at 1 and 2 years compared with usual care in elderly patients with chronic heart failure?
RCT (n=237)
Open-label (patients were not blinded to the intervention; blinded adjudication of hospitalization events)
1:1 ratio via a secure web interface tool
Yes
Does an interdisciplinary pharmacist/physician intervention involving regular structured pharmacy visits and weekly dosing aids improve health-related quality of life at 1 and 2 years compared with usual care in elderly patients with chronic heart failure?
Structured, frequent interdisciplinary community pharmacy care significantly improved 2-year heart failure-related quality of life beyond the minimal clinically important difference in elderly chronic heart failure patients.
Answers are grounded in this paper and cite their sources.
Supports adoption of interdisciplinary pharmacy care for elderly HF patients; extends randomized evidence for long-term quality-of-life benefits.
AIMS: Patients with heart failure (HF) have impaired quality of life (QoL). The randomized controlled trial PHARM-CHF investigated whether an interdisciplinary intervention consisting of regular contacts with the community pharmacy and weekly dosing aids improves medication adherence in patients with HF. It is unknown how an intervention involving frequent structured pharmacy visits affects QoL. Our aim was to explore adherence to the intervention and effects on QoL. METHODS AND RESULTS: Among 237 patients, n = 110 were randomized to pharmacy care and n = 127 to usual care. The pharmacy care group received a medication review followed by (bi-)weekly dose dispensing and counselling. The median follow-up was 2.0 years [inter-quartile range (IQR) 1.2-2.7]. Median interval between pharmacy visits was 8.4 days (IQR 8.0-10.3) and the visits lasted in median 14 min (IQR 10-15). Median adherence to the intervention was 96% (IQR 84-100). QoL at 365 days was predefined as a main secondary and at 730 days as another secondary endpoint in PHARM-CHF. QoL was measured by the Minnesota Living with Heart Failure Questionnaire; and for 111 patients (n = 47 in the pharmacy care group and n = 64 in the usual care group), data were available at baseline, and after 365 and 730 days (mean age 74 years; 41% female). Improvement in QoL was numerically higher in the pharmacy care group after 365 days and was significantly better after 730 days (difference in total scores -7.7 points [-14.5 to -1.0]; P = 0.026) compared to the usual care group. In all subgroups examined, this treatment effect was preserved. Improvements in the physical and emotional dimensions were numerically higher in the pharmacy care group after 365 days and were significantly better after 730 days: -4.0 points [-6.9 to -1.2]; P = 0.006, and -1.9 points [-3.7 to -0.1]; P = 0.039, respectively. CONCLUSIONS: A pharmacy-based interdisciplinary intervention was well received by the patients and suggests clinically important improvements in QoL.
No takes yet. Share an insight, caveat, or question.
Schulz et al. (2020) conducted an RCT in Chronic heart failure (n=237). Interdisciplinary pharmacist/physician care (comprehensive medication review, weekly/biweekly dosing aid, blood pressure/pulse measurement, and counselling) vs. Usual care (standard prescription dispensing and counselling at pharmacies of patient's choice) was evaluated on Heart failure-related quality of life measured by the Minnesota Living with Heart Failure Questionnaire (MLHFQ) total score at 730 days (MD -7.7 points, 95% CI -14.5 to -1.0, p=0.026). Interdisciplinary pharmacy care improved quality of life at 730 days compared with usual care in elderly heart failure patients.
Synapse has enriched 10 related papers. Consider them for comparative context: